Payer PolicyActive
SURG.00141 Doppler-Guided Transanal Hemorrhoidal Dearterialization
ANTHEM-SURG.00141
Anthem
Effective: July 1, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses Doppler-guided transanal hemorrhoidal dearterialization (THD/DG-HAL), including procedures with mucopexy, for treatment of internal hemorrhoids. Anthem deems this procedure investigational and not medically necessary; therefore, it is not covered. No indications or hemorrhoid grades are considered medically necessary under this policy, regardless of prior conservative treatment or FDA clearance (e.g., CPT 46948).
Coverage Criteria Preview
Key requirements from the full policy
"Doppler-guided transanal hemorrhoidal dearterialization is consideredinvestigational and not medically necessary."
Sign up to see full coverage criteria, indications, and limitations.